medicine for ovarian cancer - Page 16 of 33

DUTAXEL 100MG INJ

DUTAXEL 100MG INJ is a Schedule H drug. DUTAXEL 100MG INJ is composed of: PACLITAXEL (100.0 MG)

DUREA 500MG CAP is a Schedule H drug. DUREA 500MG CAP is composed of: HYDROXYUREA (500.0 MG)

CYTOPLATIN 50MG INFUSION is a Schedule H drug. CYTOPLATIN 50MG INFUSION is composed of: CISPLATIN (50.0 MG)

CYTOPLATIN 10MG INJ is a Schedule H drug. CYTOPLATIN 10MG INJ is composed of: CISPLATIN (10.0 MG)

CYTOGEM 200MG INJ is a Schedule H drug. CYTOGEM 200MG INJ is composed of: GEMCITABINE (200.0 MG)

CYTOGEM 1000MG INJ is a Schedule H drug. CYTOGEM 1000MG INJ is composed of: GEMCITABINE (1000.0 MG)

CYTODROX 500MG CAP is a Schedule H drug. CYTODROX 500MG CAP is composed of: HYDROXYUREA (500.0 MG)

CYTAX 30MG INJ is a Schedule H drug. CYTAX 30MG INJ is composed of: PACLITAXEL (30.0 MG)

CYTAX 300MG INJ is a Schedule H drug. CYTAX 300MG INJ is composed of: PACLITAXEL (300.0 MG)

CYTAX 260MG INJ is a Schedule H drug. CYTAX 260MG INJ is composed of: PACLITAXEL (260.0 MG)